Business of the House Debate

Full Debate: Read Full Debate
Department: Leader of the House

Business of the House

Andrew Bridgen Excerpts
Thursday 25th April 2024

(2 weeks, 1 day ago)

Commons Chamber
Read Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Penny Mordaunt Portrait Penny Mordaunt
- View Speech - Hansard - - - Excerpts

I am sorry to hear that the hon. Gentleman’s constituents have been suffering due to poor practice by those firms. He will know that under the coalition Government, new measures were introduced to crack down on things such as clamping on private land and other practices that came from such firms, and this Government take those issues very seriously. If the situations are not resolved, I think that the hon. Gentleman, when he gets the next opportunity on 16 May at Transport questions, or at other opportunities or other business questions, should name the companies. He can do that, which I find gets people in such companies to focus on resolving these issues more sensibly.

Andrew Bridgen Portrait Andrew Bridgen (North West Leicestershire) (Ind)
- View Speech - Hansard - -

In last week’s Backbench Business debate on the covid-19 pandemic response and trends in excess deaths, I asked whether it is now accepted that it was a mistake to give the respiratory suppressant drug midazolam, as part of National Institute for Health and Care Excellence guideline NG163, as treatment for those suspected of having covid-19. I also asked, should there be legal cases proving unlawful killing linked to overdoses and toxicity from midazolam, who would be held criminally responsible. Would it be the then Secretary of State for Health, NICE, NHS England or the individual doctors and nurses who administered the drug? Those questions were not answered. Can we have a statement from a Health Minister? The evasion and gaslighting on this issue has got to end.